MORE GAINS AHEAD – 63% GAIN ON THIS SUPPLIER OF A KEY COMPONENT FOR VACCINE

  Maravai LifeSciences (MRVI) is long from $25.84.   MRVI is trading at $42.25 as of this writing.  This represents a gain of 63% in a short time. MRVI reported earnings significantly better than the consensus. We have previously written that ...
Read more »

CORONAVIRUS IS PROVIDING OPPORTUNITIES IN STOCKS YOU HAVE NEVER HEARD OF

Coronavirus is providing opportunities for investors beyond well-known names.  A good example is a stock that most investors have never heard of but have provided 38% return to The Arora Report subscribers in a short ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE

Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine should provide a sharp increase in revenue. The company also has a diversified product portfolio. Zones For ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers